Skip to content
Home/Companies/Healthcare/InnoSyn
IN

InnoSyn

Healthcare·Europe·Active·3yr hold

InnoSyn is a industrials company, headquartered in Netherlands.

Entry
2023
Hold
3yr
Status
Active
Est. EV
–

Who owns InnoSyn?

InnoSyn is currently owned by Merieux Equity Partners through Mérieux Innovation 1 (2014 vintage), since 2023.

Hand-verified · updated 2026-04-21

Merieux Equity Partners
Investor
Merieux Equity Partners
Mérieux Innovation 1 · 2014 · VC

Key facts

HQNetherlands
SectorIndustrials

More from Mérieux Innovation 1

Other portfolio companies in the same fund.

Broken String Biosciences
Active
HealthcareEurope· 2023
LabQuality
Exited 2025
HealthcareEurope· 2023
to
Cairdac
Active
HealthcareEurope· 2022
Mablink Bioscience
Exited 2023
HealthcareEurope· 2022
to
SeqOne Genomics
Active
HealthcareEurope· 2022
AcuSurgical
Active
HealthcareEurope· 2021

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings